Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Part of paid clinical trials in Albany, New York.
- Sponsor
- DreaMed Diabetes
- Study ID
- NCT07599982
- Status
- Recruiting
Conditions
- Type 1 Diabetes (T1D)
- Type 2 Diabetes (T2D)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- MODI Algorithm — DEVICEAll participants use MODI insulin titration algorithm. Includes Diary app used to view treatment plans shared by MODI and manually log events (insulin intake, meal, physical activity and others) by participants; also includes a bolus calculator.
Study Details
A 13-week multi-center single-arm trial, preceded by a 2-week standard therapy phase, will be conducted to assess the safety of MODI, an insulin titration algorithm, in adults with type 1 diabetes (T1D) who use multiple daily insulin injections (MDI), or with type 2 diabetes (T2D) who use MDI, basal insulin only, or who are candidates to initiate basal insulin, in conjunction with continuous glucose monitoring (CGM).
Key Dates
- Start date
- May 25, 2026
- Status verified
- May 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 102 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: MODI dose guidance, insulin titration application
Primary Outcome Measure
CGM-measured percent time <54mg/dL [ Time Frame: 13 weeks ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| SUNY Upstate Medical Center | Albany | New York | 12246 | Malek El Muayed, MD (PRINCIPAL_INVESTIGATOR) |
| Texas Diabetes & Endocrinology | Austin | Texas | 78731 | Thomas Blevins, MD (PRINCIPAL_INVESTIGATOR) |
| Diabetes & Endocrine Treatment Specialisits (DETS) | Sandy City | Utah | 84093 | Timothy Graham, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Albany, NY
Related Studies
- Kidney Precision Medicine ProjectRecruiting · Icahn School of Medicine at Mount Sinai · Tucson, Arizona
- A Study of GNTI-122 in Adults Recently Diagnosed With T1DPHASE1 · Recruiting · GentiBio, Inc · Duarte, California
- App-Based Certified Diabetes Education Therapy (AB-CDE)Not Yet Recruiting · Oregon Health and Science University · La Jolla, California
- A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusPHASE1/PHASE2 · Recruiting · Otsuka Pharmaceutical Factory, Inc. · Chicago, Illinois